EMVision confirms clinical trial sites for NSW, Vic

EMVision Medical Devices, an Australian-listed medical device company, has signed in-principle agreements with Royal Melbourne Hospital and Liverpool Hospital for its upcoming clinical trials.

The company is developing and seeking to commercialise a medical imaging device using electromagnetic microwave imaging for diagnosis and monitoring of stroke and other medical applications. The technology is the result of over 10 years of development by researchers at The University of Queensland. The team of approximately 20 researchers is led by co-inventor Professor Amin Abbosh.

EMVision CEO Dr Ron Weinberger said, “We are pleased with the progress being made and look forward to collaborating with our study sites to advance the clinical development of our novel portable brain scanner as we seek to fulfil our mission of improving stroke patient outcomes.”

The Royal Melbourne Hospital is a stroke care centre with a tertiary academic unit that provides care for patients across Victoria. Liverpool Hospital is said to be one of the largest stroke referral centres in NSW, including an active endovascular clot retrieval service. The sites will be activated progressively, commencing with Liverpool Hospital.

EmVision is targeting study commencement this quarter; multi-centre ethics has been submitted to the Human Research Ethics Committee (HREC) and devices are in an advanced stage of commissioning, the company said in a statement. Additional trial sites will be announced progressively.

The company has appointed Avania Clinical, a global medical technology clinical research organisation (CRO), to support its upcoming multi-centre study. Avania is focused on the management of clinical studies for medical devices, IVDs, biologics and device-drug combination products internationally. Avania supports products from the first-in-human phase through the post-market phase.

Image caption: Scott Kirkland, Dr Ron Weinberger, Robert Tiller and Forough Khandan with the first-gen device (L) and early prototype (R). Image supplied.